Company / Financials
vTv Therapeutics Inc. Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$0
FY2025 · -100.0% YoY
Net Income
-$20.3M
FY2025 · -5.7% YoY
Profit Margin
-
FY2025 · net income / revenue
ROE
-31.4%
FY2025 · return on equity
Total Assets
$89.9M
FY2025
Total Debt
-
FY2025
Equity
$64.4M
FY2025
ROA
-22.5%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$0-100.0% YoYNet Income HistoryProfit after all expenses and taxes-$20.3M-5.7% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$25.5M-13.1% YoYSG&A Expense HistorySelling, general, and administrative expenses$11.9M-2.4% YoYR&D Expense HistoryResearch and development spending$13.6M+10.0% YoYInterest Expense HistoryCost of borrowing and debt obligations$12.0KIncome Tax HistoryTotal income tax expense$0-100.0% YoYTotal Assets HistoryTotal value of all assets owned$89.9M+134.9% YoYShareholders' Equity HistoryTotal assets minus total liabilities$64.4M+428.2% YoYCash & Equivalents HistoryCash and short-term liquid investments$88.9M+142.0% YoY